Page last updated: 2024-11-07

cyanex 272

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cyanex 272: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID157898
CHEMBL ID1476841
SCHEMBL ID186893
MeSH IDM0513964

Synonyms (23)

Synonym
NCGC00166110-01
83411-71-6
bis(2,4,4-trimethylpentyl)phosphinic acid
bis(2,4,4-trimethylpentyl)-phosphinic acid
phosphinic acid, bis(2,4,4-trimethylpentyl)-
phosphinic acid, p,p-bis(2,4,4-trimethylpentyl)-
einecs 280-445-7
ec 280-445-7
cyanex 272
FT-0689045
CHEMBL1476841
SCHEMBL186893
W-111573
AKOS024438132
bis(2,4,4-trimethylpentyl)phosphinicacid
c16h35o2p
J-016844
p,p-bis(2,4,4-trimethylpentyl)phosphinic acid
DTXSID60868724
CS-0032791
mfcd28145690
SY113742
A864266
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency5.62340.003245.467312,589.2998AID2517
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency89.12510.354828.065989.1251AID504847
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (54.55)29.6817
2010's2 (18.18)24.3611
2020's3 (27.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.75 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index61.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]